-
Tata India Pharma & Healthcare RegIDCW-R
Equity healthcare
Overview ( as on 12/03/25 )
NAV
₹27.47
Last change
₹-0.11 -0.0%
Fund Size (AUM)
1103.99 Cr
Performance
25.53% (5Y)
Fund Details
Tata India Pharma & Healthcare RegIDCW-R
as of 12/03/25
AUM
1103.99 Cr
Expense Ratio
2.19 %
Benchmark
Nifty Pharma TR INR
ISIN
INF277K018A5
Fund Manager
Meeta Shetty
Exit Load
0.25% if redeemed within 0-30 days
0% if redeemed after 30 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Tata India Pharma & Healthcare RegIDCW-R | 10.72% | 17.46% | 25.53% |
| Nifty Pharma TR INR | 8.93% | 17.83% | 23.17% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
11.61% |
Dr Reddy's Laboratories Ltd |
7.23% |
Aurobindo Pharma Ltd |
7.1% |
Cipla Ltd |
6.25% |
Lupin Ltd |
6.22% |
Divi's Laboratories Ltd |
5.21% |
Fortis Healthcare Ltd |
4.75% |
Apollo Hospitals Enterprise Ltd |
3.98% |
Zydus Lifesciences Ltd |
3.74% |
Aster DM Healthcare Ltd Ordinary Shares |
3.31% |
Sector Allocation
Healthcare |
97.77% |
Basic Materials |
2.23% |
Asset Allocation
-
98%
Equity
-
2%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
29.32% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
28.21% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
28.21% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
26.49% (5Y)
-
-
DSP Healthcare Fund Reg Gr
Equity healthcare-
Returns
-
25.47% (5Y)
-
-
UTI Healthcare Reg Gr
Equity healthcare-
Returns
-
26.18% (5Y)
-
